suerie moon, how do you a nswer risk. suerie moon, how do you answer those two questions?mong the vulnerable, or should you target the super spreaders first, the people? it is a great question. i think one thing we have to understand is of course, what are the characteristics of the vaccines? the ones that are currently at the front of the pack what we know from the way that those trials were designed is that we actually understand very, very little we have very little evidence, if any, as to whether they block transmission. so until we do have that data, i think it doesn't make sense, indeed, to vaccinate those who are most socially active. such as younger people. but if i may, i would like to come back to that earlier question, we know that in the us, for example, we have similar trends, in the us, for example, we have similartrends, and in the us, for example, we have similar trends, and had disproportionately bearing the burden of this pandemic, the government has actually said we should take into account not race but many of the things correlated with race, occupation

suerie moon? i fully agree with what david was saying.top of that, this is one of the reasons why we need that next generation of vaccines to continue to be developed. so, in addition to continuing the trials of the vaccines that are already being deployed, we do need to bring newer and better vaccines, and one of the characteristics that is very important is, how many doses do you need? because you can imagine, if people need to get immunised every year, it's going to make a big difference whether we can just give one dose or whether somebody has to go back twice, for example. what we see with other vaccination campaigns is that if you need to give somebody two or even three doses, the numbers of people who really show up to do that, they really drop each time. thank you very much indeed. all right, we're going to have two questions, one after the other, because they're kind of related. so, gloria akenyemi, what do you want to ask? during the pandemic, it's been widely recognised that people from a bame background are more vulnerable to

suerie moon is the co—director at the global health centre in geneva.ght be a shortfall for this kind offunding. might be a shortfall for this kind of funding. it is understandable because a lot of governments are having a hard economic time domestically but if we think about what $28 billion is in the big picture, it's reallyjust pennies. and i think it is true with many of the projections have said that this isa the projections have said that this is a great investment. we are talking about huge returns in terms of getting the global economy moving again, in terms of strengthening the medical relations and of course saving lives and ended the pandemic soonerfor some it saving lives and ended the pandemic sooner for some it makes a saving lives and ended the pandemic soonerfor some it makes a lot saving lives and ended the pandemic sooner for some it makes a lot of sense for governments to put money on the table and say we can afford $28 billion in order to put an end to this pandemic. but unfortunately we have not seen the money follow the rhetoric. s